BU PODCAST HAKKINDA 🔗

Ortalama ses uzunluğu:
7 minutes
ingilizce
Amerika Birleşik Devletleri
15 bölüm
31 Temmuz 2016beri
episodic

SON ÇIKAN BÖLÜM 🔗

Dr Franceschi speaks with ecancertv at IARC 2016 about cancer as a result of infectious pathogens. With differing rates across populations due to access to healthcare, immunocompromised status and vaccination uptake, viral and bacterial infections are becoming increasingly known as a cancer driver…

SON BÖLÜMLERİ ARA

IARC 2016 için geçmiş bölümleri ara.

ÖNCEKİ BÖLÜMLER

Dr Chanock speaks with ecancertv at IARC 2016 about increased risk of cancer passed down through heritable genetic mutations. Weighing genomics against the influence of environmental factors, Dr Chanock discusses a patients' polygenic risk score. Accurate scoring and stratification may not only r…
Prof Sir Marmot speaks with ecancertv at IARC 2016 about the challenges facing healthcare as a result of systematic inequality on a national and international scale. He discusses the impact on life expectancy between and within countries depending on lifestyle and access to care, and the importanc…
Prof Peto speaks with ecancertv at IARC 2016 about the means by which he believes cancer diagnoses can be halved. He outlines the necessary steps of tackling the social and environmental causes of cancer, specifically smoking and infectious diseases. Looking at global cancer incidences, Prof Peto…
Prof Beral speaks with ecancertv at IARC 2016 about prevalence and prevention of cancer affecting women. With specific attention to breast cancer, she discusses the influence of child-bearing patterns, contraceptive pills and hormone replacement therapy on disease rates across the world.
Dr Eils speaks with ecancertv at IARC 2016 about the volume of data produced by genomic sequencing on a personal and industrial level, and how to translate this into medically actionable information. Druggable mutations are drivers behind many tumours, and Dr Eils details how determining the root …
Dr Vineis speaks with ecancertv at IARC 2016 about the exposome, changes in patient biology as a result of damage acquired through environment or behaviour rather than a transcriptional mutation. He describes the efforts to investigate the impact of dietary, contamination and air pollution on glob…
Dr van Hemelrijck speaks with ecancertv at IARC 2016 about the conflicting results of metformin to treat prostate cancer. Metformin, a widely available diabetes treatment, is variably associated with slowing or aggravating cancer, which may be due to the apparent protection from cancer associated …
Prof Blackburn speaks to ecancertv at IARC 2016 about the shortening of telomeres, its genetic and non-genetic influences and the possible tumourigenic outcomes. She outlines molecular and behavioural causes for altered telomere degeneration, including chronic stress, diet, and how these predictab…
Dr Denny speaks with ecancertv at IARC 2016 about access to cancer care in Africa. Given the prevalence of infectious diseases associated with tumourigenesis, such as hepatitis, HIV and Helicobacter pylori, Dr Denny discusses preventative measures currently available, including the issues of cost …
Feragatname: Bu sayfaya yerleştirilmiş podcast ve sanat eserleri, sahibinin mülkiyetinde olan ve Listen Notes, Inc.'e bağlı olmayan veya tarafından onaylanmayan ecancer.org'e aittir.